Business
Viatris Named U.S. In-House Legal Team of the Year for Intellectual Property Litigation by LMG Life Sciences
PITTSBURGH, Nov. 18, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named the winner in three
About this update from Viatris Inc.
[{"type":"text","content":"PITTSBURGH, Nov. 18, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named the winner in three categories at the 10th annual LMG Life Sciences 2022 Americas Awards, highlighting companies, law firms and legal practitioners behind the most innovative and challenging life science work in the regulatory, corporate, intellectual property and litigation areas.\nViatris received the recognition as U.S. In-House Legal Team of the Year for Intellectual Property Litigation after achieving significant victories in several patent litigation matters. Those included favorable outcomes relating to generic Tecfidera and generic Lantus, as well as cases establishing new law regarding the appropriate venue for pharmaceutical patent litigation. Additionally, Viatris cases relating to generic Tecfidera and venue, which both succeeded in appellate court, were recognized by LMG as Hatch-Waxman Impact Cases of the Year.\n\"It is truly an honor to be recognized with such a prestigious award, especially when considering the caliber of the other nominated in-house legal teams,\" said Brian Roman, Global General Counsel, Viatris. \"Our Intellectual Property Litigation group has always operated on the foundation of respecting legitimate, valid intellectual property rights. We not only have a strong track record of defending Viatris' own IP, but also enjoy unparalleled success in discerning and defeating weak or invalid patents as others assert them in attempts to gain unearned monopolies and erect unjustified barriers. I'm incredibly proud of the many contributions to IP law that our team has made through its courtroom victories while clearing the way for patients to gain access to Viatris' high quality, affordable medicines.\n\"I also congratulate Jill Ondos, Deputy Global General Counsel and head of all litigation for Viatris, and Tom Jenkins, our Global Head of IP Litigation, for their unceasing commitment to excellence and to fulfilling our mission of empowering people worldwide to live healthier at every stage of life, regardless of geography or circumstance. It is truly a pleasure to see our entire IP litigation team be recognized as In-House Legal Team of the Year.\"\nBeing recognized by LMG follows previous accolades for Viatris, comprising inclusion on Forbes' list of World's Best Em...